George Fred Wilkinson, Pres-Global Brands&Biosimilars at Actavis, Inc. (ACT), sold 16,749 shares at $138.00 ($2.3M) on 2013-09-04, disclosed to the SEC on 2013-09-06.
Open-market sale of $2.3M ACT by Pres-Global Brands&Biosimilars. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |